CUMYL-CB-MEGACLONE (CUMYL-CBMGACLONE, SGT-273) is a
gamma-carboline based
synthetic cannabinoid
Synthetic cannabinoids, or neocannabinoids, are a class of designer drug molecules that Binding affinity, bind to the same receptors to which cannabinoids (Tetrahydrocannabinol, THC, Cannabidiol, CBD and many others) in cannabis plants attach. Th ...
receptor agonist that has been sold as a
designer drug
A designer drug is a structural or functional analog of a controlled substance that has been designed to mimic the pharmacological effects of the original drug, while avoiding classification as illegal and/or detection in standard drug tests. ...
, first being identified in Hungary in April 2020.
Analytical data for Cumyl-Cb-MeGaClone. Hungarian Institute for Forensic Science, 9 April 2020
/ref>
See also
* 5F-CUMYL-PEGACLONE
* CUMYL-5F-P7AICA
5F-CUMYL-P7AICA (also known as CUMYL-5F-P7AICA or SGT-263) is a pyrrolo ,3-byridine-3-carboxamide based synthetic cannabinoid that has been sold as a designer drug. It was first identified by the EMCDDA in February 2015.
See also
* 5F-A-P7AI ...
* CUMYL-CH-MEGACLONE
* CUMYL-BC-HPMEGACLONE-221
* CUMYL-CBMINACA
CUMYL-CBMINACA (SGT-277) is an indazole-3-carboxamide based synthetic cannabinoid receptor agonist that has been sold as a designer drug, first being identified in Germany in February 2020. It is illegal in Finland.
See also
* CUMYL-3TMS-PRINA ...
* CUMYL-THPINACA
CUMYL-THPINACA (also known as SGT-42) is an indazole-3-carboxamide based synthetic cannabinoid. CUMYL-THPINACA acts as a potent agonist
An agonist is a chemical that activates a Receptor (biochemistry), receptor to produce a biological respon ...
References
Cannabinoids
Designer drugs
Gamma-Carbolines
{{cannabinoid-stub